Effects of a community-based adapted boxing program on physical capacity and quality of life in individuals with Parkinson disease over a 12 month period
Objective: The main objective was to assess long-term effects of a community-based adapted boxing program on physical capacity and QoL in individuals with mild, or…Motor subtype change between OFF and ON periods in patients with Parkinson’s disease
Objective: To identify if there is any difference in the motor subtype of PwPD between "off" stage and "on" stage. Background: Patients with Parkinson’s disease…Effect of the MAO-B inhibitor and glutamate modulator safinamide on depressive symptoms in three Parkinson’s disease patients
Objective: Patients suffering from Parkinson’s disease experience various motor and non-motor symptoms. Within the range of non-motor symptoms depression is reported as high as in…Efficacy and safety/tolerability of opicapone in catechol-O-methyltransferase inhibitor-naïve Parkinson’s disease patients recently diagnosed with motor fluctuations
Objective: To evaluate the potential added benefit of opicapone (OPC), compared with placebo (PLC) and entacapone (ENT), in catechol-O-methyltransferase inhibitor (COMTi)-naïve Parkinson’s disease (PD) patients…The influence of ANNK1/DRD2 haplotypes on the onset of complications of long-term levodopa therapy in Parkinson’s disease
Objective: To investigate an influence of selected polymorphisms in DRD2 and ANKK1 genes on the occurrence of complications of long-term levodopa therapy in Serbian PD…Targeting the Receptor of Glial Cell Line-Derived Neurotrophic factor to treat Parkinson’s Disease
Objective: Our goal is to develop small molecules which support and restore nigrostriatal dopamine neurons by activation of glial cell line-derived-neurotrophic factor (GDNF) receptors. Background:…Secondary Vascular Parkinsonism: Role of increasing levels cortisol in the cognitive impairment
Objective: Elevated cortisol levels are found in many diseases, including infectious, related to aging, depression, and associated with a depressive status. Elevated cortisol levels are…Atypical Psychogenic Nonepileptic Seizure (PNES) preceding Multiple System Atrophy (MSA)
Objective: To share a case report of Atypical PNES and MSA. Background: Multiple system atrophy (MSA) is a rare neurodegenerative diagnosis that clinically presents with…MRI evaluation of Progressive Supranuclear Palsy
Objective: We aimed to evaluate the magnetic resonance imaging-derived parameters in differentiation of patients with progressive supranuclear palsy from patients with Parkinson’s disease and other…Use of Figurative Language in Describing OFF Periods in Parkinson’s Disease
Objective: To explore the use of figurative language by individuals with Parkinson’s disease (PD) describing their experience during OFF periods. Background: OFF periods are characterized…
- « Previous Page
- 1
- …
- 5
- 6
- 7
- 8
- 9
- …
- 149
- Next Page »